Literature DB >> 31591913

Exosomal miR-320d derived from adipose tissue-derived MSCs inhibits apoptosis in cardiomyocytes with atrial fibrillation (AF).

Lina Liu1, Haoran Zhang2, Hongyu Mao1, Xiaohong Li1, Yamin Hu1.   

Abstract

MicroRNAs (miRNAs) play a key role in various pathological processes like atrial fibrillation (AF), which is a common cardiac arrhythmia. Exosomes are essential information carrier in the intercellular communication. Therefore, this study aimed to investigate the effects of exosomal miR-320d on cardiomyocytes with AF and related mechanisms. To do this, AMSCs were transfected with miR-320d mimics, AMSCs-derived exosomes were co-cultured with cardiomyocytes with AF. MTT, TUNEL staining, flow cytometry, real-time PCR, western blots, and luciferase reporter assays were performed. The results revealed that miR-320d expression was decreased in AF cardiomyocytes. AF increased apoptosis and reduced cell viability in cardiomyocytes. By transfection with miR-320d mimics, the miR-320d level was increased in AMSCs, exosomes and cardiomyocytes, which reversed the effect of AF on cardiomyocytes. STAT3 was down-regulated in AF cardiomyocytes and was a direct target gene of miR-320d. Inhibition of STAT3 abolished the effect of modified exosomes in cardiomyocytes, causing decreased apoptosis and increased cell viability. Taken together, the results suggested that exosomal miR-320d was associated with AF cardiomyocytes apoptosis and cell viability and that the effect of miR-320d on cardiomyocytes is STAT3-dependent. Therefore, this study provides a novel understanding of the molecular basis of AF and provides insight into therapeutic strategies for AF.

Entities:  

Keywords:  Atrial fibrillation; STAT3; exosome; mesenchymal stem cells; miR-320d

Mesh:

Substances:

Year:  2019        PMID: 31591913     DOI: 10.1080/21691401.2019.1671432

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  19 in total

Review 1.  Adipose-Derived Stem Cell Exosomes and Related microRNAs in Atherosclerotic Cardiovascular Disease.

Authors:  Fan Zhou; Ke Li; Keping Yang
Journal:  J Cardiovasc Transl Res       Date:  2022-10-12       Impact factor: 3.216

Review 2.  A systematic review on the role of MSC-derived exosomal miRNAs in the treatment of heart failure.

Authors:  Yesica Abril Botello-Flores; Martha Yocupicio-Monroy; Norma Balderrábano-Saucedo; Alejandra Contreras-Ramos
Journal:  Mol Biol Rep       Date:  2022-04-01       Impact factor: 2.742

Review 3.  Extracellular Circular RNAs Act as Novel First Messengers Mediating Cell Cross-Talk in Ischemic Cardiac Injury and Myocardial Remodeling.

Authors:  Mengyang Li; Wei Ding; Gaoli Liu; Jianxun Wang
Journal:  J Cardiovasc Transl Res       Date:  2022-02-19       Impact factor: 3.216

Review 4.  Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy.

Authors:  Bashdar Mahmud Hussen; Goran Sedeeq Hama Faraj; Mohammad Fatih Rasul; Hazha Jamal Hidayat; Abbas Salihi; Aria Baniahmad; Mohammad Taheri; Soudeh Ghafouri-Frad
Journal:  Cancer Cell Int       Date:  2022-10-18       Impact factor: 6.429

5.  LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition.

Authors:  Boyu Yan; Ting Liu; Chang Yao; Xinglong Liu; Qian Du; Lihua Pan
Journal:  Lab Invest       Date:  2021-08-13       Impact factor: 5.662

6.  CD146+Mesenchymal stem cells treatment improves vascularization, muscle contraction and VEGF expression, and reduces apoptosis in rat ischemic hind limb.

Authors:  Tao Chen; Bo Ye; Jing Tan; Haifeng Yang; Faming He; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2021-04-21       Impact factor: 6.100

7.  Attenuation of hepatic ischemia‑reperfusion injury by adipose stem cell‑derived exosome treatment via ERK1/2 and GSK‑3β signaling pathways.

Authors:  Yaqing Zhang; Yonghua Li; Qilong Wang; Dongyu Zheng; Xue Feng; Wei Zhao; Linlin Cai; Qingqing Zhang; Haitao Xu; Hailong Fu
Journal:  Int J Mol Med       Date:  2021-12-08       Impact factor: 4.101

Review 8.  Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.

Authors:  Kun Xiang; Muhammad Akram; Walaa Fikry Elbossaty; Jinfu Yang; Chengming Fan
Journal:  Heart Fail Rev       Date:  2021-07-12       Impact factor: 4.654

Review 9.  Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation.

Authors:  Carolina Balbi; Ambra Costa; Lucio Barile; Sveva Bollini
Journal:  Cells       Date:  2020-03-15       Impact factor: 6.600

10.  LncRNA Nuclear-Enriched Abundant Transcript 1 Regulates Atrial Fibrosis via the miR-320/NPAS2 Axis in Atrial Fibrillation.

Authors:  Huangdong Dai; Naishi Zhao; Hua Liu; Yue Zheng; Liang Zhao
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.